Zevra Therapeutics (KMPH) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 44 252 sessions, February 28, 2022 to February 28, 2023
- Largest daily move
- -14% close of November 10, 2022
- 1-year change
- -2% closing prices, February 28, 2022 to February 28, 2023
- 5-year change
- -93.8% closing prices, February 28, 2018 to February 28, 2023
Company Description
Zevra Therapeutics (Nasdaq: KMPH) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $200.5M.
KMPH has declined 2.0% over the past year. The last closing price was $5.81.
This page collects what Stock Titan holds for KMPH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Zevra Therapeutics (KMPH) closed at $5.81 on February 28, 2023. Over the past 12 months, the price has lost 2.0%.
KMPH Metrics & Rankings
Price returns through February 28, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Zevra Therapeutics has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings. View all KMPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
KMPH Company Profile & Sector Positioning
Zevra Therapeutics (KMPH) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing KMPH often look at related companies in the same sector, including GENFIT S.A. American (GNFT), Tiziana Life Sciences Ltd. (TLSA), Tenaya Therapeutics, Inc. (TNYA), Cognition Therapeutics, Inc. (CGTX), and MediWound Ltd. (MDWD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KMPH's relative position within its industry.